**Core Concept**
The diagnosis of Cervical Intraepithelial Neoplasia (CIN) 2 signifies a precancerous lesion on the cervix, necessitating further evaluation and management to prevent progression to invasive cancer. CIN 2 is characterized by the presence of abnormal cells that are confined to the lower two-thirds of the cervical epithelium.

**Why the Correct Answer is Right**
The next step in managing CIN 2 is to perform a biopsy, preferably a colposcopy-guided biopsy, to obtain a definitive histological diagnosis. This allows for the assessment of the extent of cellular abnormalities and the presence of any high-grade lesions. A colposcopy is a crucial diagnostic tool that enables the visualization of the cervix's surface, facilitating the identification of any lesions or abnormalities.

**Why Each Wrong Option is Incorrect**
**Option A:** A Pap smear is a screening tool, not a diagnostic tool, and would not provide sufficient information for managing CIN 2.
**Option B:** Cone biopsy is usually reserved for cases where a definitive diagnosis cannot be obtained by colposcopy-guided biopsy.
**Option C:** Hysterectomy is a radical intervention and is typically reserved for cases of invasive cancer or severe cervical dysplasia.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the management of CIN 2 should be individualized, taking into account factors such as the patient's age, reproductive plans, and the extent of the lesion.

**Correct Answer: C. Cone biopsy is usually reserved for cases where a definitive diagnosis cannot be obtained by colposcopy-guided biopsy.**